Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C2605
http://purl.obolibrary.org/obo/NCIT_C2605
|
|---|---|
| Preferred Name | Beta Alethine |
| Definitions |
A disulfide agent that stimulates T and B-cell functions and exhibits anti-tumor and immunostimulant activity. (NCI)
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A disulfide agent that stimulates T and B-cell functions and exhibits anti-tumor and immunostimulant activity. (NCI) |
|---|---|
| prefLabel | Beta Alethine
|
| label | Beta Alethine
|
| PDQ_Closed_Trial_Search_ID | 38126
|
| code | C2605
|
| prefixIRI | NCIT:C2605
|
| in_subset | |
| Preferred_Name | Beta Alethine
|
| FDA_UNII_Code | LY583605Y8
|
| Contributing_Source | FDA
|
| Maps_To | Beta Alethine
|
| CAS_Registry | 646-08-2
|
| NCI_Drug_Dictionary_ID | 38126
|
| Legacy Concept Name | Beta_Alethine
|
| type | |
| ALT_DEFINITION | A substance that is being studied as a treatment for cancer. It belongs to a family of chemicals called disulfides.
|
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 38126
|
| Semantic_Type |
Organic Chemical
Pharmacologic Substance
|
| UMLS_CUI | C0290021
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |